Jingui Shenqi Wan alleviates bone loss induced by primary osteoporosis by inhibiting osteoblast pyroptosis
Abstract Objective The primary objective of this study was to elucidate the underlying pharmacological mechanisms by which Jingui Shenqi Wan (JGSQW) alleviates postmenopausal osteoporosis (PMOP). Through a systematic investigation, we sought to identify the specific molecular pathways through which...
Saved in:
Main Authors: | Yuwangxuan Qian, Yihe Yu, Fan Yang, Qixing Liang, Dan Xu, Jiaxiang Chen, Xueqin Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Journal of Orthopaedic Surgery and Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13018-025-05542-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Elucidating the metabolic mechanisms and active constituents of ZuoGui Wan in combatting postmenopausal osteoporosis: A metabolomics and network pharmacology approach
by: Yanchen Feng, et al.
Published: (2025-02-01) -
Ketogenic diet and β-hydroxybutyrate in osteoporosis: current progress and controversy
by: Changfang Luo, et al.
Published: (2025-01-01) -
Association of dietary niacin intake with osteoporosis in the postmenopausal women in the US: NHANES 2007–2018
by: Li Li, et al.
Published: (2025-02-01) -
Association Between Allometric Body Shape Indices and Osteoporosis in Postmenopausal Women: A Cross-Sectional Study from NHANES
by: Zhao S, et al.
Published: (2025-01-01) -
Associations of comprehensive dietary antioxidant index with postmenopausal femur bone mineral density and osteoporosis: data from the national health and nutrition examination survey
by: Jianbo Sun, et al.
Published: (2025-01-01)